Subcomponent Vaccine Based on CTA1-DD Adjuvant with Incorporated UreB Class II Peptides Stimulates Protective Helicobacter pylori Immunity

Why can’t we make an effective vaccine against Helicobacter pylori?

(2013) Philip Sutton et al.   Expert Review of Vaccines

Th1-Mediated Immunity against Helicobacter pylori Can Compensate for Lack of Th17 Cells and Can Protect Mice in the Absence of Immunization

(2013) Hua Ding et al.   PLoS One

Identification of two novel immunodominant UreB CD4+ T cell epitopes in Helicobacter pylori infected subjects

(2013) Wu-Chen Yang et al.   VACCINE

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Treatment of Helicobacter pylori infection 2012

(2012) Bojan Tepes et al.   HELICOBACTER

Vaccine-Induced Immunity Against Helicobacter pylori in the Absence of IL-17A

(2011) Elizabeth S. DeLyria et al.   HELICOBACTER

Vaccinating against Helicobacter pylori infection

(2011) Steven J. Czinn et al.   Nature Reviews Gastroenterology & Hepatology

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus

(2011) Dubravka Grdic Eliasson et al.   VACCINE

Proinflammatory Cytokine Gene Expression in the Stomach Correlates with Vaccine-Induced Protection againstHelicobacter pyloriInfection in Mice: an Important Role for Interleukin-17 during the Effector Phase

(2010) Carl-Fredrik Flach et al.   INFECTION AND IMMUNITY

Sublingual Immunization Protects against Helicobacter pylori Infection and Induces T and B Cell Responses in the Stomach

(2010) S. Raghavan et al.   INFECTION AND IMMUNITY

A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori

(2010) Carl-Fredrik Flach et al.   VACCINE

Interleukin-17 Is a Critical Mediator of Vaccine-Induced Reduction of Helicobacter Infection in the Mouse Model

(2009) Dominique Velin et al.   GASTROENTEROLOGY

Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model

(2009) Wei-Ying Zhou et al.   VACCINE

Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin

(2009) Nancy A. Summerton et al.   VACCINE

Safety and Immunogenicity of an Intramuscular Helicobacter pylori Vaccine in Noninfected Volunteers: A Phase I Study

(2008) Peter Malfertheiner et al.   GASTROENTEROLOGY

Vaccination of Mice Against H pylori Induces a Strong Th-17 Response and Immunity That Is Neutrophil Dependent

(2008) Elizabeth S. DeLyria et al.   GASTROENTEROLOGY

CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization

(2008) C. Sundling et al.   JOURNAL OF GENERAL VIROLOGY

CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine

(2008) Dubravka Grdic Eliasson et al.   VACCINE